United States generic drugs market
is expected to grow at a significant rate during the forecast period. Generic drugs contain the active ingredients same as
existing branded drug. Active ingredient are chemical substances that carries
the effect of medication. Generic drugs are in high demand as they are much
cheaper than the branded drugs as they do not need to account for high
development cost of medicines and associated research activities. Supportive
government policies which are promoting the manufacturing of alternative
generic drugs and make them available to patients, as they aid in bringing down
the healthcare costs. Strong economic position of the United States and
well-developed healthcare infrastructure is boosting the growth of the generic
drugs market. Increasing prevalence of chronic diseases and the need for
effective treatment is fueling the generic drugs demand in United States. Large
availability of generics drug gives patient easy access to choose any of the
alternatives which is the major reason for lower abandonment of prescription
drugs. Raise in awareness among the patients regarding the benefits of healthy
lifestyle and early diagnosis and treatment is fostering the demand for generic
drugs in United States.
States generic drugs market is segmented into type, mode of drug delivery,
form, source, distribution channel, application, regional distribution, and
on distribution channel, generic drugs market can be divided into hospital
pharmacies, retail pharmacies, online pharmacies, and others. The hospital
pharmacies segment is expected to account for major market share for the
forecast period, 2022-2026. Presence and development of healthcare facilities
and huge patient in-flow into the hospitals is driving factor for high demand
of generic drugs in hospital pharmacies. Favorable reimbursement policies and
presence of disposable income to afford medical treatment is aiding to increase
the generic drug market growth.
The major players operating in the
United States generic drugs market are Pfizer Inc., Abbott
Laboratories, Inc., Teva Pharmaceuticals USA, Inc., Eli Lilly and Company, Sandoz
US, Sun Pharma Inc., Par Pharmaceutical Companies, Inc., Endo Pharmaceuticals
Inc, Lupin Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., among others.
Major companies are developing advanced technologies and launching new services
to stay competitive in the market. Other competitive strategies include mergers
& acquisitions and new service developments.
Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022–2026
Objective of the
- To analyze the historical growth of the market
size of United States generic drugs market from 2016 to 2019.
- To estimate and forecast the market size of United
States generic drugs market from 2020 to 2026 and growth rate until 2026.
- To classify and forecast United States generic
drugs market based on type, mode of drug delivery, form, source,
distribution channel, application, regional distribution, and company.
- To identify dominant region or segment in the United
States generic drugs.
- To identify drivers and challenges for United
States generic drugs market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in United
States generic drugs market.
- To identify and analyze the profile of leading
players operating in United States generic drugs market.
- To identify key sustainable strategies adopted
by market players in United States generic drugs market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers who
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of United States generic drugs market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Generic drugs device manufacturing
- Market research and
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums, and
alliances related to generic drugs market.
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
In this report, United States generic
drugs market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
United States Generic Drugs Market,
- Small Molecule Generics
- United States Generic Drugs Market, By Mode of
- United States Generic Drugs Market, By Form:
- United States Generic Drugs Market, By Source:
- In House
- United States Generic Drugs Market, By Distribution
- United States Generic Drugs Market, By Application:
- United States Generic Drugs Market, By Region:
- North East
Company Profiles: Detailed analysis of the major
companies present in United States generic drugs market.
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
United States generic drugs
market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]
- Detailed analysis and
profiling of additional market players (up to five).